José Vitor Mota Lemos MS , Joyce Ohana de Lima Martins MS , Larissa Carvalho Machado DDS , Lara Rabelo Aragão MS , Maria Elisa Quezado Lima Verde PhD , Cláudia do Ó. Pessoa PhD , Maria Júlia Barbosa Bezerra PhD , Ana Paula Negreiros Nunes Alves PhD , Paulo Goberlânio de Barros Silva PhD
{"title":"Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats","authors":"José Vitor Mota Lemos MS , Joyce Ohana de Lima Martins MS , Larissa Carvalho Machado DDS , Lara Rabelo Aragão MS , Maria Elisa Quezado Lima Verde PhD , Cláudia do Ó. Pessoa PhD , Maria Júlia Barbosa Bezerra PhD , Ana Paula Negreiros Nunes Alves PhD , Paulo Goberlânio de Barros Silva PhD","doi":"10.1016/j.oooo.2024.08.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA).</div></div><div><h3>Study Design</h3><div>Forty male Wistar rats were divided into a negative control group (0.1 mL/kg saline), a positive control group (ZA, 0.20 mg/kg), and three test groups treated with ZA and digoxin at 1 (DG1), 2 (DG2), or 4 (DG4) mg/kg. These groups received treatment three times weekly. ZA was administered intravenously on days 0, 7, and 14, followed by extraction of the left lower first molar on day 42, a final ZA dose on day 49, and euthanasia on day 70. Analyses included radiographic, histomorphometric, and immunohistochemical evaluation of the mandibles, western blotting of gingiva, and mechanical tests on femurs. Statistical analysis was performed using ANOVA/Bonferroni tests (<em>P</em> < .05).</div></div><div><h3>Results</h3><div>Digoxin reduced radiolucency of MRONJ (<em>P</em> < .001), inflammatory cells, empty osteocyte lacunae (<em>P</em> < .001), apoptotic osteoclasts (<em>P</em> < .001), and Caspase-3-positive osteocytes (<em>P</em> = .021). ZA increased immunoreactivity for most markers except c-Fos, while digoxin reduced interleukin 17, TNF-α, IL-6, IL-2, FOXP3, c-Jun, NFκB (<em>P</em> < .001), TGF-β (<em>P</em> = .009), RANKL (<em>P</em> = .035), and OPG (<em>P</em> = .034). Digoxin also reversed RORγt expression (<em>P</em> < .001), increased diarrhea scores (<em>P</em> = .028), renal and cardiac indexes (<em>P</em> < .001), and enhanced femur mechanical properties (<em>P</em> < .013).</div></div><div><h3>Conclusions</h3><div>Digoxin attenuated MRONJ by inhibiting RORγt and reducing the Th17 response.</div></div>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":"138 6","pages":"Pages 781-793"},"PeriodicalIF":2.0000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212440324004474","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
The study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA).
Study Design
Forty male Wistar rats were divided into a negative control group (0.1 mL/kg saline), a positive control group (ZA, 0.20 mg/kg), and three test groups treated with ZA and digoxin at 1 (DG1), 2 (DG2), or 4 (DG4) mg/kg. These groups received treatment three times weekly. ZA was administered intravenously on days 0, 7, and 14, followed by extraction of the left lower first molar on day 42, a final ZA dose on day 49, and euthanasia on day 70. Analyses included radiographic, histomorphometric, and immunohistochemical evaluation of the mandibles, western blotting of gingiva, and mechanical tests on femurs. Statistical analysis was performed using ANOVA/Bonferroni tests (P < .05).
Results
Digoxin reduced radiolucency of MRONJ (P < .001), inflammatory cells, empty osteocyte lacunae (P < .001), apoptotic osteoclasts (P < .001), and Caspase-3-positive osteocytes (P = .021). ZA increased immunoreactivity for most markers except c-Fos, while digoxin reduced interleukin 17, TNF-α, IL-6, IL-2, FOXP3, c-Jun, NFκB (P < .001), TGF-β (P = .009), RANKL (P = .035), and OPG (P = .034). Digoxin also reversed RORγt expression (P < .001), increased diarrhea scores (P = .028), renal and cardiac indexes (P < .001), and enhanced femur mechanical properties (P < .013).
Conclusions
Digoxin attenuated MRONJ by inhibiting RORγt and reducing the Th17 response.
期刊介绍:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology is required reading for anyone in the fields of oral surgery, oral medicine, oral pathology, oral radiology or advanced general practice dentistry. It is the only major dental journal that provides a practical and complete overview of the medical and surgical techniques of dental practice in four areas. Topics covered include such current issues as dental implants, treatment of HIV-infected patients, and evaluation and treatment of TMJ disorders. The official publication for nine societies, the Journal is recommended for initial purchase in the Brandon Hill study, Selected List of Books and Journals for the Small Medical Library.